Identifying Cancer Cachexia Using Clinical Reasoning AI – ASCO 2026

Press Release: Pangaea Expands its AI Platform to Support Decision-Making & Guideline-Concordance for MDT Tumor Boards Across Enterprise & Community Care

Microsoft & NVIDIA Documentary: Pangaea Data Closing Care Gaps

GO BACK

Pharmaceutical Success Stories

share this

Breakthrough AI to Characterize Hard to Diagnose Conditions to Find More Patients and Auto-Generate Regulatory Reports

Tuesday, November 16th at 12:00 PM EST (9:00 AM PT/ 5:00 PM GMT)

Hear from Dr. Rick Sax, former SVP at IQVIA, AstraZeneca and Merck, on how pharmaceutical companies are applying Pangaea’s novel AI for characterizing hard to diagnose diseases to find 95% more patients, improve screening success rates by 400% and save 80-90% time by automatically generating clinical narratives for regulatory reports.

Request Recording